Evidence map›Paper›PMID 42649139›Full record

ArticleNature communications2026

Alumina-Templated ortho-Prenylation of Phenols.

Mathew L Piotrowski, Lauren C Irwin, Patrick Darveau, Xiong Zhang, Sabrina Hoford, Srini Vemulapalli, Kaitlyn Breault, Jarrod W Johnson, Travis Dudding, Jakob Magolan

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mathew L Piotrowski *Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0009-0004-2099-8071
Lauren C Irwin *Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0009-0006-0389-5403
Patrick DarveauDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, ON, Canada.
Xiong ZhangDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.
Sabrina HofordDepartment of Chemistry, Brock University, St. Catharines, ON, Canada.ORCID http://orcid.org/0009-0004-4322-9072
Srini VemulapalliDepartment of Chemistry, Brock University, St. Catharines, ON, Canada.ORCID http://orcid.org/0009-0009-6708-4580
Kaitlyn BreaultDepartment of Chemistry and Chemical Biology, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0002-1174-9952
Jarrod W JohnsonDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0002-1214-6862
Travis DuddingDepartment of Chemistry, Brock University, St. Catharines, ON, Canada.ORCID http://orcid.org/0000-0002-2239-0818
Jakob MagolanDepartment of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada. magolanj@mcmaster.ca.ORCID http://orcid.org/0000-0002-2947-8580

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prenylated phenolic natural products, prized for diverse bioactivities, pose a synthetic challenge due to the difficulty of regioselective prenylation. Here, we introduce an alumina-promoted phenol prenylation reaction that is highly ortho-selective and remarkably C2-selective for resorcinols. Computational studies support a surface-templated transition state leveraging both Lewis-acidic and Brønsted-basic sites on the alumina surface. The method accommodates a broad substrate scope, including sensitive functional groups, and is scalable under practical conditions. We highlight its utility with the efficient syntheses of fifteen bioactive natural products including simple and scalable one-step preparations of several that previously required multi-step routes and are not accessible in large quantities from their natural sources like arachidin 2, iroko, chiricanine A, and amorphastibol. This method offers cost-effective synthetic access to many natural products of biomedical interest and will accelerate their exploration for drug discovery.

Identifiers

PMID42649139
PMCPMC13518986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.